Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling

NCT01323894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2016-06-17

No results posted yet for this study

Summary

The first year purpose:

The best concentration of canonical Wnt3a will be investigated in promoting the osteoblastogenesis of human mesenchymal stem cells.

Conditions

  • Primary Disease

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Sopha Chia-Ning Chang, M.D. Ph.D. · China Medical University Hospital

Eligibility

Min Age
10 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-08-31
Completion
2013-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01323894 on ClinicalTrials.gov